openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of CV Sciences, Inc. (OTC: CVSI)

02-04-2020 10:58 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in CV Sciences, Inc. (OTC: CVSI) shares.

An investigation on behalf of current long term investors in CV Sciences, Inc. (OTC: CVSI) shares.

An investigation on behalf of current long-term investors in shares of CV Sciences, Inc. (OTC: CVSI) concerning potential breaches of fiduciary duties by certain directors and officers of CV Sciences, Inc. was announced.

Investors who are current long term investors in CV Sciences, Inc. (OTC: CVSI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in CV Sciences, Inc. (OTC: CVSI stocks follows a lawsuit filed against CV Sciences, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: CVSI stocks, concerns whether certain CV Sciences, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Nevada the plaintiff alleges that the Defendants failed to disclose that its Patent #15/426,617 received a non-final rejection from the USPTO on April 27, 2017, that a final rejection from the USPTO on December 14, 2017, and that as a result of the foregoing, Defendants' statements about CV Sciences' business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

Those who purchased shares of CV Sciences, Inc. (OTC: CVSI) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of CV Sciences, Inc. (OTC: CVSI) here

News-ID: 1919161 • Views: 977

More Releases from Shareholders Foundation

Investigation announced for current long-term Investors in Deutsche Bank Aktieng …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Deutsche Bank Aktiengesellschaft. Investors who purchased shares of Deutsche Bank Aktiengesellschaft (NYSE: DB) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Deutsche Bank Aktiengesellschaft directors breached their fiduciary duties and caused damage to the company and its shareholders. On August 25,
Investigation announced for Long-Term Investors in Forte Biosciences, Inc. (NASD …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Forte Biosciences, Inc. Investors who purchased shares of Forte Biosciences, Inc. (NASDAQ: FBRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Forte Biosciences directors breached their fiduciary duties and caused damage to the company and its shareholders. Torrance, CA
Investigation announced for long-term Investors in Illumina, Inc. (NASDAQ: ILMN) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Illumina, Inc.. Investors who purchased shares of Illumina, Inc. (NASDAQ: ILMN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Illumina, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. On August 18, 2021,
DiDi Global Inc. (NYSE: DIDI) Long Term Investor Investigation over potential Wr …
An investigation on behalf of investors in shares of DiDi Global Inc. (NYSE: DIDI) concerning potential breaches of fiduciary duties by certain directors and officers of DiDi Global Inc. Investors who are current long term investors in DiDi Global Inc. (NYSE: DIDI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in

All 5 Releases


More Releases for Sciences

BOC Sciences Launched Impurities for Scientific Research
BOC Sciences, headquartered in Shirley, New York, announced that a rich collection of impurities are now available for scientific research use on July 27, 2018. In the process of drug development and manufacturing, profiling and controlling impurities level is of considerable importance as their side pharmaceutical effects may affect the efficacy and safety of active pharmaceutical ingredients (APIs). In most cases, an exceeding amount of impurity level would lead
Bayer Crop Sciences Ltd
Bayer Crop Sciences Ltd Bayer Crop Sciences Ltd- Company Profile & Financial Analysis” contains in depth information and data about the company and its operations. You will find information on the business structure, areas of operation, products and services offered by the company. It also comprises SWOT analysis, key ratios, historical financial data and insider’s view on financial stability and industrial ranking with financial forecasts for two- year period. This report is
Global Life Sciences BPO Market
The Global Life Sciences BPO Market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights.Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO). Request Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/24 Increasing demand for low cost
Global life sciences BPO market
TheGlobal life sciences BPO market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights.Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO). Request Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/24 Increasing demand for low cost drugs,
Deposition Sciences Increases Photolithography Patterning Capacity
• New 200 mm diameter wafer enhances photolithography capability Santa Rosa, CA – Deposition Sciences, Inc. (DSI®), manufacturer of highly durable thin film optical coatings, introduces an enhanced capability to manufacture patterned optical filters. DSI has increased its capacity and resolution with the introduction of a new photolithography production line capable of patterning 200 mm diameter wafers. Director of marketing and sales, Michael Newell, notes, “We are very excited
Nanotechnology Applications to Revolutionize Biomedical Sciences
Nanoparticles play a vital role in the field of biomedical sciences. The applications of nanotechnology in biomedical sciences represent several opportunities to deal with complicated diseases (cancer, cardiac, and neurodegenerative disorders, infection, etc). Private and public research efforts worldwide are developing nanoproducts aimed at improving health care and advancing medical research. Some of these products have entered the marketplace and more are on the verge of doing so. The potential